These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35610178)

  • 1. Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety.
    Kondej M; Wróbel TM; Targowska-Duda KM; Leandro Martínez A; Koszła O; Stępnicki P; Zięba A; Paz A; Wronikowska-Denysiuk O; Loza MI; Castro M; Kaczor AA
    ChemMedChem; 2022 Aug; 17(15):e202200238. PubMed ID: 35610178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs.
    Kondej M; Wróbel TM; Silva AG; Stępnicki P; Koszła O; Kędzierska E; Bartyzel A; Biała G; Matosiuk D; Loza MI; Castro M; Kaczor AA
    Eur J Med Chem; 2019 Oct; 180():673-689. PubMed ID: 31357129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic.
    Kaczor AA; Targowska-Duda KM; Budzyńska B; Biała G; Silva AG; Castro M
    Neurochem Int; 2016 Jun; 96():84-99. PubMed ID: 26964765
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kaczor AA; Targowska-Duda KM; Silva AG; Kondej M; Biała G; Castro M
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32102432
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscarinic receptors as a target for drugs treating schizophrenia.
    Bymaster FP; Felder C; Ahmed S; McKinzie D
    Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):163-81. PubMed ID: 12769625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand.
    Kaczor AA; Targowska-Duda KM; Stępnicki P; Silva AG; Koszła O; Kędzierska E; Grudzińska A; Kruk-Słomka M; Biała G; Castro M
    Neurochem Int; 2021 Jun; 146():105016. PubMed ID: 33722679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous activation of muscarinic and GABA
    Cieślik P; Woźniak M; Tokarski K; Kusek M; Pilc A; Płoska A; Radulska A; Pelikant-Małecka I; Żołnowska B; Sławiński J; Kalinowski L; Wierońska JM
    Behav Brain Res; 2019 Feb; 359():671-685. PubMed ID: 30267715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
    Shayegan DK; Stahl SM
    CNS Spectr; 2004 Oct; 9(10 Suppl 11):6-14. PubMed ID: 15475871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget 1,4-Dioxane Compounds Combining Favorable D
    Del Bello F; Ambrosini D; Bonifazi A; Newman AH; Keck TM; Giannella M; Giorgioni G; Piergentili A; Cappellacci L; Cilia A; Franchini S; Quaglia W
    ACS Chem Neurosci; 2019 May; 10(5):2222-2228. PubMed ID: 30609891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance.
    Rasmussen T; Fink-Jensen A; Sauerberg P; Swedberg MD; Thomsen C; Sheardown MJ; Jeppesen L; Calligaro DO; DeLapp NW; Whitesitt C; Ward JS; Shannon HE; Bymaster FP
    Schizophr Res; 2001 Apr; 49(1-2):193-201. PubMed ID: 11343877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.
    Kasper S; Tauscher J; Küfferle B; Barnas C; Pezawas L; Quiner S
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():83-9. PubMed ID: 10654113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S; Remington G
    Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors.
    Ueda T; Ugawa S; Ishida Y; Shimada S
    Eur J Pharmacol; 2011 Dec; 671(1-3):79-86. PubMed ID: 21951966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
    Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
    J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.
    Fontenla JA; Osuna J; Rosa E; Castro ME; G-Ferreiro T; Loza-García I; Calleja JM; Sanz F; Rodríguez J; Raviña E
    J Med Chem; 1994 Aug; 37(16):2564-73. PubMed ID: 7914540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel N-sulfonyl-2-indoles that behave as 5-HT
    Saavedra OM; Karila D; Brossard D; Rojas A; Dupuis D; Gohier A; Mannoury la Cour C; Millan MJ; Ortuno JC; Hanessian S
    Bioorg Med Chem; 2017 Jan; 25(1):38-52. PubMed ID: 28029458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity.
    Chłoń-Rzepa G; Bucki A; Kołaczkowski M; Partyka A; Jastrzębska-Więsek M; Satała G; Bojarski AJ; Kalinowska-Tłuścik J; Kazek G; Mordyl B; Głuch-Lutwin M; Wesołowska A
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1048-62. PubMed ID: 26406608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.